Prolactin, immunoregulation, and autoimmune diseases

Seminars in Arthritis and Rheumatism

Volumn 20, Issue 5, 1991, Pages 273-284

  Jara, Luis J ^a,b   Lavalle, Carlos ^b   Fraga, Antonio ^b   Gómez Sanchez, Celso ^a   Silveira, Luis H ^a   Martinez Osuna, Pindaro ^a   Germain, Bernard F ^a   Espinoza, Luis R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

autoimmunity; immunoregulation; Prolactin

Indexed keywords

PROLACTIN;

ADJUVANT DISEASE; ARTICLE; AUTOIMMUNITY; ETIOLOGY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE; PRIORITY JOURNAL; RAT;

ANIMAL; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; CYTOKINES; ENZYME ACTIVATION; HUMAN; IMMUNE SYSTEM; KILLER CELLS, NATURAL; LYMPHOCYTES; PROLACTIN; PROTEIN KINASE C; SUPPORT, NON-U.S. GOV'T;

EID: 0025863722     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-0172(91)90028-X     Document Type: Article

References (93)

1. A complete regulatory loop between the immune and neuroendocrine systems
2. Interactions between the neuroendocrine and immune systems Common hormones and receptors
3. Effects of stress on the immune system
4. Hormones and the immune response
5. Immunomodulators and feeding regulation: A humoral link between the immune and nervous system
6. Immune-mediated encephalitis on the role of antigen-presenting cells in brain tissue
7. The effect of prolactin and growth hormone on hemolymphopoietic tissue and immune function
8. New aspects of prolactin and immunity A lymphocyte-derived prolactin-like product and nuclear protein kinase C activation
9. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus
10. Prolactin and gonadal hormones in pregnant SLE patients
11. Action du lobe anterieur del'hyphophysesur la montee laiteuse
12. Regulation of prolactin secretion at the level of the lactotroph
13. Structural features of prolactin and growth hormones that can be related to their biological properties
14. Prolactin synthesis by human chorion decidual tissue: a possible source of amniotic fluid prolactin
15. Prolactin production by human endometrium during the normal menstrual cycle
16. Nonrandom ectopic protein production by malignant cells: Direct evidence in vitro
17. Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity
18. A human B-lymphoblastoid cell line produces prolactin
19. Distribution of immunoreactive prolactin in the male and female rat brain: Effects of hypophysectomy and intraventricular administration of colchicine
20. Control of prolactin secretion
21. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells
22. Interleukin-1-β modulation of prolactin secretion from rat anterior pituitary cells: involvement of adenylate cyclase activity and calcium mobilization
23. Interleukin 6 possibly induced by interleukin 1β in the pituitary gland stimulates the release of gonadotropins and prolactin
24. Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro
25. Physiologically significant inhibitory hypothalamic action of substance P on Prolactin release in the male rat
26. Perspectives in platelet-activating factor research
27. Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis
28. Release of platelet-activating factor in systemic lupus erythematosus
29. The effect of hypophysectomy upon the involution of the thymus in the rat
30. Antigenic mimicry between mycobacteria and cartilage proteoglycans: the model of adjuvant arhtritis
31. Animal models of reactive arthritis
32. Immunodeficiency in hypophysectomized rats
33. Regulation of humoral in rats by pituitary hormones
34. Regulation of immunity in rats by lactogenic and growth hormones
35. Immunomodulation by bromocriptine
36. Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin
37. Bromocriptine microcapsules inhibit ornithine decarboxylase activity induced by Freund's complete adjuvant in lymphoid tissues of male rats
38. Freund's complete adjuvant induces ornithine decarboxylase activity in the central nervous system of male rats and triggers the release of pituitary hormones
39. Tumor necrosis factor inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors
40. Interferon-Γ inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures
41. Methylacetylenic putrescine (MAP) an inhibitor of polyamine biosynthesis prevents the development of collagen-induced arthritis
42. Immunization against heterologous type II collagen induces arthritis in mice
43. Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis
44. Bromocriptine suppresses postpartum exacerbation of collageninduced arthritis
45. T lymphocytes in collagen II-induced arthritis in mice: Characterization of arthritogenic collagen II-specific T-cell lines and clones
46. Prolactin stimulates transcription of growthrelated genes in Nb2 T Lymphoma cells
47. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic
48. Inhibition of lymphocyte proliferation by antibodies to prolactin
49. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes
50. Receptormediated mitogenic action of prolactin in a rat lymphoma cell line
51. Cyclosporine: A new immunosuppressive agent for organ transplantation
52. Cyclosporin A inhibits ornithine decarboxylase induction in kidney in response to prolactin, growth hormone and insulin
53. Cyclic AMP dependent protein kinase activation and the induction of ornithine decarboxylase during lymphocyte mitogenesis
54. Prolactin receptors on human lymphocytes and their modulation by cyclosporine
55. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosporine
56. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine
57. Lymphokines
58. Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion
59. Tyrosine.phosphorylation of a 66,000 Mr soluble protein in lectin-activated human peripheral blood T lymphocytes
60. Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring
61. Prolactin stimulation of protein kinase C activity in rat aortic smooth muscle
62. Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen
63. Prolactin and known modulators of rat splenocytes activate nuclear protein kinase C
64. Radiofrequency destruction of the tuberoinfundibolar region of hypotalamus permanently abrogates NK cell activity in mice
65. Reduced number of natural killer cells in patients with pathological hyperprolactinemia
66. Natural killer activity in hyperprolactinemic patients
67. Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporin A
68. Thyroid autoimmunity in hyperprolactinaemic disorders
69. Immunological abnormalitied with hyperprolactinemia
70. T-cell dysregulation in patients with hyperprolactinemia: Effect of bromocriptine treatment
71. Decreased production of and response to interleukin 2 by cultured lymphocytes from patients with systemic lupus erythematosus
72. T lymphocyte immune dysfunctions in systemic lupus erythematosus
73. Is prolactin trophic to the intestine in coeliac disease?
74. Chloroquine affects prolactin secretion and Golgi morphology in the mammotroph
75. Intravenous immunoglobulin and bromocriptine in the treatment of refractory neuropsychiatrie systemic lupus erythematosus
76. Bromocriptine (Br) decreases early mortality in female NZB/w mice
77. Diurnal hormone variation in fibromyalgia syndrome: A comparison with rheumatoid arthritis
78. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain)
79. Endogenous iridocyclitis relieved during treatment with bromocriptine
80. Ovarian function studies in active ankylosing spondylitis in women. Clinical response to estrogen therapy
81. Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat
82. Downregulation of autoantibody levels of cyclosporine and bromocriptine treatment in patients with uveitis
83. Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine
84. Bromocriptine and cyclosporine A combination therapy in rheumatoid arthritis
85. Zur behandlung der Psoriasis arthropathica mit Bromocriptin
86. Prolactin predicts cardiac allograft rejection in cyclosporine immunosuppressed patients
87. Prolactin as a marker of rejection in human heart transplantation
88. Analysis of risk factors for acute allograft rejection after heart transplantation
89. The effect of hypoprolactinemia alone and in combination with cyclosporine on allograft rejection
90. Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation
91. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritissusceptible Lewis rats
92. A central nervous system defect in biosynthesis of corticotropinreleasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats